Current issues in the development of disease-modifying drugs for Alzheimer's disease

被引:0
|
作者
Okamura, Nobuyuki [1 ]
机构
[1] Tohoku Univ, Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
3-S-04-1
引用
收藏
页码:S56 / S56
页数:1
相关论文
共 50 条
  • [1] Disease-modifying drugs in Alzheimer's disease
    Ghezzi, Laura
    Scarpini, Elio
    Galimberti, Daniela
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 1471 - 1479
  • [2] Disease-modifying drugs and vaccines for Alzheimer's disease
    Cummings, J.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S40 - S40
  • [3] Management of Alzheimer's disease using disease-modifying drugs
    Gauthier, Serge
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (04) : 375 - 378
  • [4] Emerging amyloid disease-modifying drugs for Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (01) : 5 - 7
  • [5] Overview of potential targets for disease-modifying drugs in Alzheimer's disease
    Cuello, A. Claudio
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 4 - 4
  • [6] Neuroinflammation in Alzheimer's disease:: Potential targets for, disease-modifying drugs
    Hüll, M
    Hampel, H
    [J]. NEUROINFLAMMATION - FROM BENCH TO BEDSIDE, 2002, 39 : 159 - 178
  • [7] Current Models for Development of Disease-Modifying Osteoarthritis Drugs
    Makarczyk, Meagan J.
    Gao, Qi
    He, Yuchen
    Li, Zhong
    Gold, Michael S.
    Hochberg, Mark C.
    Bunnell, Bruce A.
    Tuan, Rocky S.
    Goodman, Stuart B.
    Lin, Hang
    [J]. TISSUE ENGINEERING PART C-METHODS, 2021, 27 (02) : 124 - 138
  • [8] Development of disease-modifying therapies against Alzheimer's disease
    Iwatsubo, Takeshi
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (09) : 491 - 494
  • [9] Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease
    Kulshreshtha, Akanksha
    Piplani, Poonam
    [J]. NEUROLOGICAL SCIENCES, 2016, 37 (09) : 1403 - 1435
  • [10] Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
    Akanksha Kulshreshtha
    Poonam Piplani
    [J]. Neurological Sciences, 2016, 37 : 1403 - 1435